Eleni Gavriilaki Selected Research

Thrombotic Microangiopathies

6/2022	Novel Insights into Factor D Inhibition.
6/2022	Genetic and Functional Evidence of Complement Dysregulation in Multiple Myeloma Patients with Carfilzomib-Induced Thrombotic Microangiopathy Compared to Controls.
1/2022	Advancing therapeutic complement inhibition in hematologic diseases: PNH and beyond.
12/2021	Role of the lectin pathway of complement in hematopoietic stem cell transplantation-associated endothelial injury and thrombotic microangiopathy.
9/2021	Predictors of Transplant-Associated Thrombotic Microangiopathy in Patients With Overlap or Chronic Graft-vs-Host-Disease.
1/2021	Genetic justification of severe COVID-19 using a rigorous algorithm.
5/2020	A New Era in Endothelial Injury Syndromes: Toxicity of CAR-T Cells and the Role of Immunity.
4/2020	Pretransplant Genetic Susceptibility: Clinical Relevance in Transplant-Associated Thrombotic Microangiopathy.
1/2020	Complementopathies and precision medicine.
1/2020	An Update in Drug-Induced Thrombotic Microangiopathy.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eleni Gavriilaki Research Topics

Disease

16	Thrombotic Microangiopathies 06/2022 - 06/2015
10	Hypertension (High Blood Pressure) 03/2021 - 03/2013
8	Essential Hypertension 03/2021 - 01/2012
7	Graft vs Host Disease (Graft-Versus-Host Disease) 12/2021 - 10/2017
6	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 06/2022 - 06/2015
5	Hemolysis 03/2022 - 05/2016
5	Neoplasms (Cancer) 11/2021 - 01/2012
4	HELLP Syndrome 03/2022 - 05/2016
4	Inflammation (Inflammations) 01/2022 - 01/2019
4	Hematologic Neoplasms (Hematological Malignancy) 05/2021 - 10/2017
4	Infections 01/2020 - 01/2015
4	Atypical Hemolytic Uremic Syndrome 01/2020 - 06/2015
3	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 06/2022 - 01/2020
3	COVID-19 02/2022 - 12/2021
3	Thrombosis (Thrombus) 01/2022 - 09/2018
3	Sickle Cell Anemia (Hemoglobin S Disease) 01/2021 - 09/2018
2	Thrombocytopenia (Thrombopenia) 03/2022 - 09/2021
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2019
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 03/2017
2	Hematologic Diseases (Blood Diseases) 01/2022 - 10/2019
2	Vascular System Injuries 01/2022 - 12/2020
2	Transfusion Reaction 01/2022 - 01/2021
2	Hemorrhage 12/2021 - 11/2019
2	Leukemia 05/2021 - 01/2019
2	Neuromyelitis Optica (Devic's Disease) 10/2020 - 01/2020
2	Myasthenia Gravis 10/2020 - 01/2020
2	Multiple Sclerosis 10/2020 - 01/2019
2	Hemolytic-Uremic Syndrome 01/2020 - 01/2019
2	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2020 - 01/2020
2	Type 2 Diabetes Mellitus (MODY) 01/2020 - 01/2019
2	Thrombotic Thrombocytopenic Purpura 01/2019 - 06/2015
2	Rheumatoid Arthritis 01/2019 - 07/2013
2	Chronic Kidney Failure (Chronic Renal Failure) 07/2015 - 01/2015
1	Multiple Myeloma 06/2022
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2022
1	Thromboinflammation 01/2022
1	Pneumonia (Pneumonitis) 12/2021
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 12/2021
1	Capillary Leak Syndrome 12/2021
1	Bacterial Infections (Bacterial Infection) 01/2021
1	Hemoglobinopathies 01/2021
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2021
1	Anemia 01/2021
1	Asymptomatic Diseases 01/2021
1	Congenital Hemolytic Anemia (Hemolytic Anemia, Congenital) 01/2021
1	Epilepsy (Aura) 10/2020
1	Huntington Disease (Huntington's Disease) 10/2020
1	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 10/2020
1	Stroke (Strokes) 10/2020
1	Guillain-Barre Syndrome 10/2020
1	Nervous System Diseases (Neurological Disorders) 10/2020
1	Polyneuropathies (Polyneuropathy) 10/2020
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 10/2020
1	Thrombophilia 05/2020
1	Hyperglycemia 01/2020
1	Kidney Diseases (Kidney Disease) 01/2020

Drug/Important Bio-Agent (IBA)

20	Complement System Proteins (Complement)IBA 06/2022 - 06/2015
5	eculizumab FDA Link 01/2022 - 05/2016
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2019
4	Complement Inactivating AgentsIBA 01/2022 - 05/2016
3	EnzymesIBA 03/2022 - 05/2016
3	CytokinesIBA 03/2021 - 01/2012
3	Pharmaceutical PreparationsIBA 01/2020 - 01/2017
3	Retinaldehyde (Retinal)IBA 12/2014 - 03/2013
2	LectinsIBA 01/2022 - 12/2021
2	Biological ProductsIBA 01/2022 - 09/2021
2	treosulfanIBA 11/2021 - 03/2017
2	Hydroxyurea (Hydrea)FDA LinkGeneric 01/2021 - 12/2014
2	Sickle HemoglobinIBA 01/2021 - 01/2021
2	AntibodiesIBA 10/2020 - 01/2020
2	A-factor (Streptomyces)IBA 01/2019 - 07/2015
2	thiamine triphosphorate (TTP)IBA 01/2019 - 06/2015
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2019 - 10/2018
2	Busulfan (Busulfex)FDA Link 10/2018 - 03/2017
2	AldosteroneIBA 01/2018 - 08/2014
2	Vitamin D FDA LinkGeneric 07/2014 - 07/2013
2	Antihypertensive Agents (Antihypertensives)IBA 07/2014 - 04/2014
2	Angiotensin Receptor AntagonistsIBA 07/2014 - 04/2014
1	carfilzomibIBA 06/2022
1	Proteasome InhibitorsIBA 06/2022
1	VaccinesIBA 02/2022
1	sutimlimabIBA 01/2022
1	ravulizumabIBA 01/2022
1	narsoplimabIBA 01/2022
1	pegcetacoplanIBA 01/2022
1	fludarabineIBA 11/2021
1	ruxolitinibIBA 09/2021
1	Toll-Like Receptors (Toll-Like Receptor)IBA 03/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2021
1	CoagulantsIBA 12/2020
1	Chimeric Antigen ReceptorsIBA 05/2020
1	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 01/2020
1	AlbuminsIBA 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020

Therapy/Procedure

16	Cell Transplantation 11/2021 - 03/2017
11	Therapeutics 06/2022 - 01/2014
5	Transplantation 06/2022 - 09/2017
4	Hematopoietic Stem Cell Transplantation 12/2021 - 10/2018
4	Renal Dialysis (Hemodialysis) 07/2016 - 01/2015
2	Immunotherapy 12/2021 - 05/2020